🇺🇸 FDA
Patent

US 7510726

Methods and compositions for deterring abuse of opioid containing dosage forms

granted A61KA61K31/485A61K47/32

Quick answer

US patent 7510726 (Methods and compositions for deterring abuse of opioid containing dosage forms) held by Acurx Pharmaceuticals, Inc. expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Acurx Pharmaceuticals, Inc.
Grant date
Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/485, A61K47/32, A61K47/34, A61K47/38